Country: Australia
Bahasa: Inggeris
Sumber: Department of Health (Therapeutic Goods Administration)
pamidronate disodium, Quantity: 15 mg
Sandoz Pty Ltd
pamidronate disodium
Injection, concentrated
Excipient Ingredients: water for injections; sodium hydroxide; mannitol; phosphoric acid
Intravenous
4, 1
Medicine Registered
(S4) Prescription Only Medicine
Treatment of conditions associated with increased osteoclast activity: predominantly lytic bone metastases from breast cancer and advanced multiple myeloma; acute management of tumour-induced hypercalcaemia (Hypercalcaemia of malignancy); treatment of symptomatic Paget's disease of bone.
Visual Identification: Clear, colourless solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius
Registered
2006-01-23